Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy

NCT03121846 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators